Citadel Advisors
HOOK

Citadel Advisors’s HOOKIPA Pharma HOOK Stock Holding History

Citadel Advisors’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,400
Closed -$4.75K – 13588
2025
Q1 		$4.75K Buy
4,400
+800
+22% +$1.32K ﹤0.01% 13868
2024
Q4 		$7.24K Buy
3,600
+1,220
+51% +$3.77K ﹤0.01% 13746
2024
Q3 		$10.2K Buy
2,380
+710
+43% +$3.75K ﹤0.01% 13216
2024
Q2 		$9.88K Sell
1,670
-870
-34% -$6.9K ﹤0.01% 13122
2024
Q1 		$18.1K Buy
+2,540
New +$18.1K ﹤0.01% 13075
2023
Q4 		– Sell
-1,340
Closed -$8.25K – 14699
2023
Q3 		$8.25K Hold
1,340
– – ﹤0.01% 13204
2023
Q2 		$11.8K Sell
1,340
-1,660
-55% -$18.4K ﹤0.01% 13118
2023
Q1 		$22.1K Buy
3,000
+870
+41% +$7.79K ﹤0.01% 12997
2022
Q4 		$17.3K Buy
2,130
+1,010
+90% +$10.9K ﹤0.01% 13258
2022
Q3 		$15K Sell
1,120
-1,390
-55% -$21.3K ﹤0.01% 12158
2022
Q2 		$41K Sell
2,510
-820
-25% -$13.6K ﹤0.01% 12048
2022
Q1 		$76K Buy
3,330
+1,900
+133% +$34.1K ﹤0.01% 12514
2021
Q4 		$33K Sell
1,430
-980
-41% -$39.4K ﹤0.01% 13438
2021
Q3 		$142K Buy
2,410
+930
+63% +$67.4K ﹤0.01% 12442
2021
Q2 		$136K Sell
1,480
-1,740
-54% -$232K ﹤0.01% 12603
2021
Q1 		$433K Buy
+3,220
New +$388K ﹤0.01% 10008

Other funds holding HOOK

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors's HOOK Position: Q2 2025 in Review

Citadel Advisors sold out of HOOKIPA Pharma (HOOK) in Q2 2025, closing a stake of 10,366 shares — an estimated $11.2K sold.

Citadel Advisors first reported a position in HOOK in Q1 2021 and held it in 12 quarters. The position peaked at $587K in Q2 2021. 27 funds tracked by Wall St. Rank hold HOOK as of Q2 2025.

  • Citadel Advisors reported no remaining HOOKIPA Pharma position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 10,366 HOOKIPA Pharma shares in Q2 2025, an estimated $11.2K.
  • Citadel Advisors first reported a position in HOOKIPA Pharma in Q1 2021 and held it in 12 quarters.
  • Citadel Advisors's HOOKIPA Pharma position peaked at $587K in Q2 2021.
  • 27 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.